Clinical trial
A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease
NCT05378529 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease
- Lead sponsor
- Amgen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 19, 2022
- Completion date
- December 30, 2023
- Enrollment
- 39,480 (actual)
- Sites
- 735
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerotic cardiovascular disease